echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > NEJM: The role of Aedes aegypti infected with Wolbachia in controlling dengue fever

    NEJM: The role of Aedes aegypti infected with Wolbachia in controlling dengue fever

    • Last Update: 2021-06-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Dengue fever is an acute viral syndrome transmitted by mosquitoes caused by any of the four serotypes of Dengue virus (DENV)
    .


    In 2019, the World Health Organization listed dengue fever as one of the top ten global health threats


    Approximately 50 million to 100 million symptomatic cases appear worldwide every year


    Management There are currently few randomized trials of Aegypti mosquito control methods, and none of the trials use virological confirmation of dengue fever (VCD) as a judging endpoint


    Wolbachia pipientis-a common, maternally inherited, obligate intracellular bacteria-can infect a variety of insects, but it does not naturally infect Aedes aegypti
    .


    Stable transfection of Aedes aegypti with certain Wolbachia strains gives them resistance to DENV and other arboviruses


    Infected Aedes aegypti and stability in some of the Wolbachia strains transfected gives them to DENV infection and other arboviruses spread of resistance


    They conducted a cluster randomized trial in Yogyakarta, Indonesia, involving the release of wMel-infected Aegypti mosquitoes to control dengue fever
    .


    We randomly assigned 12 geographic clusters to receive the deployment of wMel-infected Aedes aegypti (intervention cluster) and 12 clusters that did not receive deployment (control cluster)


    In this experiment, after successfully infiltrating wMel into the intervention cluster, a total of 8144 participants were recruited;3721 people lived in the intervention cluster, and 4423 people lived in the control cluster
    .


    In the intention-to-treat analysis, 67 (2.


    Experimental results show that introducing the wMel gene into the Aedes aegypti population can effectively reduce the incidence of symptomatic dengue fever and reduce the number of participants who are hospitalized due to dengue fever
    .

    Introducing the wMel gene into the Aedes aegypti population can effectively reduce the incidence of symptomatic dengue fever and reduce the number of hospitalizations for the participants due to dengue fever
    .


     

    Original link: https:// href="https://" target="_blank" rel="noopener">https:// of Wolbachia-Infected Mosquito Deployments for the Control of Dengue
    Adi Utarini, MD, Ph.


    D.



    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.